Brandon Hensinger is Global Vice President at Yikon Genomics, President of Avrio Genetics, and Founder of The Ascent Institute. He he has been at the forefront of many innovative breakthroughs. Most notably, he led the launch of the world’s first Non-Invasive PGT-A Technology, which is an embryo screening technology that uses non-invasive practices to help physicians choose healthy embryos for transfer, for women going through fertility treatments with Yikon Genomics. He has a passion for continued learning, specifically in the field of reproductive endocrinology and embryology.
Brandon has a strong reputation as a global speaker, leading sales executive, entrepreneur, and leader in the global reproductive genetics industry. Through his company Avrio Genetics, he is consulted for his expertise in developing business models, strategic plans, and distribution channels for genetic laboratories, nationally and globally. Avrio Genetics currently manages international launches for 7 companies, with a growing portfolio. He also has extensive experience in M&A due diligence operations for national and global companies.
The Ascent Institute was founded in order to blend adventure and climbing with executive leadership development. Through The Ascent Institute’s innovative excursions and adventure programs, business executives can explore professional development in a unique way, learning through experience, and bringing those lessons back in to their respective companies.
Brandon is fluent in Spanish and Portuguese, and conversational Mandarin. He has a passion for learning new languages. Outside of his business life, Brandon is a competitive triathlete, rock climber, skateboarder, and musician